GlassScriptPhysician profile
Eric J Foltz
NPI 1063550978
$21,143.29
in general payments reported to CMS, 2019-2025
82 companies · $3,311 in 2025
The $3,311 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,283 · 2020: $2,088 · 2021: $2,607 · 2022: $3,272 · 2023: $3,367 · 2024: $3,216 · 2025: $3,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,893.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $2,225.35 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Abbvie INC. | $1,680.54 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,619.20 | 2019-2025 | |
| Biogen, INC. | $1,602.03 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Teva Pharmaceuticals USA, INC. | $1,235.22 | 2019-2025 | Ajovy, Austedo |
| Alexion Pharmaceuticals, INC. | $820.43 | 2019-2025 | Ultomiris, Soliris |
| Amgen INC. | $648.77 | 2019-2025 | Uplizna |
| Emd Serono, INC. | $635.64 | 2019-2025 | Mavenclad |
| Genzyme Corporation | $538.44 | 2019-2025 | |
| Lilly USA, LLC | $524.36 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Supernus Pharmaceuticals, INC. | $454.86 | 2019-2022 | |
| Celgene Corporation | $450.31 | 2021-2025 | Zeposia |
| Jazz Pharmaceuticals INC. | $442.29 | 2019-2025 | |
| Sk Life Science, INC. | $427.20 | 2020-2025 | |
| Inspire Medical Systems, INC. | $421.54 | 2019-2025 | Inspire |
Show all 82 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Foltz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.